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A DNP Nurse-Managed Hepatitis C Clinic, Improving Quality of Life in a Rural
Area
Abstract
Hepatitis C is quickly becoming a national threat, involving 2% of the nation’s population, ranking this as
the 11th most prevalent disease in the world. Traditionally, treatment for hepatitis C has been conducted
in tertiary care settings, limiting access to care for those residing in rural areas. Improving access to care
through the development of a Doctor of Nursing Practice (DNP) nurse-managed clinic in a rural setting
will improve health outcomes and quality of life for those treated outside the traditional setting. Caring for
those living in less densely populated areas requires an understanding of rural culture. This paper will
discuss the development and implementation of a DNP Model of Care for rural patients being treated for
hepatitis C. The model of care starts with identifying hepatitis C, treating the patient following established
medical guidelines, using the nursing model to monitor clinical progress and managing side-effects
caused by the treatment medications. Using the DNP Model of Care, a patient-focused clinic can
successfully treat rural patients utilizing the principles of the Effect Theory for management and the
Process Theory for ongoing evaluation. Collaboration with other key resources, utilizing a
multidisciplinary approach allows the DNP nurse to care for those requiring treatment for chronic
hepatitis C, where they live and work with the assistance of family and social support.
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ABSTRACT:
Hepatitis C is quickly becoming a national threat, involving 2% of the nation’s population,
ranking this as the 11th most prevalent disease in the world. Traditionally, treatment for hepatitis
C has been conducted in tertiary care settings, limiting access to care for those residing in rural
areas. Improving access to care through the development of a Doctor of Nursing Practice (DNP)
nurse-managed clinic in a rural setting will improve health outcomes and quality of life for those
treated outside the traditional setting. Caring for those living in less densely populated areas
requires an understanding of rural culture. This paper will discuss the development and
implementation of a DNP Model of Care for rural patients being treated for hepatitis C. The
model of care starts with identifying hepatitis C, treating the patient following established
medical guidelines, using the nursing model to monitor clinical progress and managing sideeffects caused by the treatment medications. Using the DNP Model of Care, a patient-focused
clinic can successfully treat rural patients utilizing the principles of the Effect Theory for
management and the Process Theory for ongoing evaluation. Collaboration with other key
resources, utilizing a multidisciplinary approach allows the DNP nurse to care for those requiring
treatment for chronic hepatitis C, where they live and work with the assistance of family and
social support.
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The Institute of medicine (IOM) considers hepatitis C a major health problem and a
major cause of liver disease.1 Approximately 4.1-4.9 million people are affected with hepatitis C
(HCV) in the United States, accounting for 1.8-2.0% of the general population, 2,3,4resulting in
8,000-10,000 deaths annually.5,8 Ranked as the 11th most prevalent disease in the world,6 there
are 170 million cases of HCV responsible for 1.4 million deaths per year worldwide,3,4,5,6 but
these numbers are difficult to obtain without a national hepatitis C surveillance program.1 These
statistics are expected to triple in the next 10-20 years,8 positioning HCV as a “global epidemic”
in the new millennium,9 even as it has been termed the next “hidden epidemic”.10 HCV is the
most common blood-borne infection in the United States and is the leading cause of liver
transplants.8,11,12,13 The Organ Procurement and Transplantation Network located in the U.S.,
states that 6,320 patients underwent liver transplantation in 2009 for treatment of end-stage liver
failure, with nearly 17,000 patients currently waiting for a donor liver.14 Approximately 75%85% of acutely infected individuals progress to chronic infection with up to 20% developing
cirrhosis over 20-30 years, putting them at risk for end-stage liver disease and hepatocellular
carcinoma (HCC) 4,15 and possible severe quality of life impairment. The risk of HCC is 1%-4%
per year when cirrhosis of the liver is present,13 and this is expected to increase over the next
decade due to the slow progression of the disease. HCC is the third leading cause of cancer
deaths in the worldwide, the fifth most common cancer among men and the eight most common
cancer among women.14 Antiviral therapy is considered standard of care even when eradication
of the virus may not occur, as it reduces the risk of developing malignancy.15Because of routine
screening of blood products, the number of new HCV cases is declining, but the rates of HCV
associated morbidity and mortality will continue to rise4 for the next 20-30 years. Though the
incidence of acute and chronic hepatitis A and B are diminishing in this country, and
theoretically eradication of these diseases could occur over the next 20 years through standard

vaccination, HCV has multiple types and subspecies with a high rate of mutation, making
vaccine development very difficult. Until a vaccine is developed, reducing the spread of the
HCV needs to be continued though the identification of risk factors.

Rural Nursing and Quality of Life
Rural Nursing poses challenges and opportunities for unique care and is different from
urban nursing due the essentials attributes and culture of this population. This nursing has been
identified as providing health care by professional nurses to persons living in sparsely populated
areas,16 though these areas are not well defined. Rural can mean country, agriculture, or just in
terms of assumed culture. Sparsely populated can be defined anywhere between 3 and 1,000
persons per square mile. DNP nurses working in any setting require a model of care with a
theory base by which to practice and rural nursing is no exception. Once diagnosed with HCV,
rural patients may not start treatment due to inconvenient access to specialist care,17 which is
traditionally available in tertiary care settings located in urban areas. Rural health care providers
are expected to do more with less and accept responsibilities not usually seen by providers in the
urban setting. Health and work beliefs, isolation, distance, outsider/insider concept, selfreliance, and lack of anonymity of familiarity are concepts identified with the rural community.18
Lack of health accessibility is a major factor with the rural patient. Transportation, distance,
isolation, weather, finances, time of year (including planting and harvesting of crops, and
hunting season), attitudes toward health and patient education may be barriers to care and all
must be considered before hepatitis treatment is considered.19 Seasonal agricultural farm
workers who are transient and are of a different culture may be included as a subset population.
Understanding these concepts of rural nursing will require the DNP to create an evidence-based
plan of care for the HCV patient undergoing treatment.

Side effects experienced by patients may be minimal or quite severe. The most common
reason to discontinue treatment is psychiatric side-effects such as depression, 20 suicidal and
homicidal thoughts. “Road rage” has been seen in some patients. Rural areas may few mental
health clinics, thus primary care providers may be the only source of care. Keeping the primary
care provider aware of treatment any psychiatric concerns early in treatment may avoid disaster
from side effects. Do not hesitate to discuss with the collaborating hepatologist and discontinue
treatment if necessary.
Theoretical Framework
Nursing case management, provided by public health nurses and social workers, has been
in practice since the 1800’s to improve health care to immigrants and those who could not afford
health care. Nursing clinics that include APN’s offer services to the uninsured and underserved
that have chronic illnesses. The DNP with advanced preparation will add diagnostic skills and,
clinical management to those with chronic illness and in need of patient-focused care. The
Doctor of Nursing Practice Model of Care focuses on the patient, allowing the DNP to oversee
the hepatitis C treatment while managing response to treatment and monitoring any side effects
of care. The office visits, laboratory monitoring and documentation by both the patient and
managing nurse allow improved compliance and success rates in treatment. Critical thinking and
decision making by APN’s are made with evidence-based information and a theoretical base.
The Effect Theory brings together scientific facts and behaviors to deliver interventions and
predict outcomes.21 This theory demonstrates a relationship between behavioral factors, disease
causality, with moderating and mediating mechanisms, and disease treatment outcomes. The
identification of risk factors as described by the model will allow an accurate testing of possible
disease and prediction of outcomes. 22 The theoretical framework used to implement this model

of care for the treatment of HCV is the Effect Theory, see Figure 1. This combination theory
provides the reader with an understanding of the complexity of HCV in the rural setting and its
impact for treatment outcomes. The DNP nurse practicing in a rural setting can best understand
the needs of the HCV patient as this is where the patient is living and where primary intervention
occurs. The DNP also appreciates the cultural complexities of the rural setting. (Figure 1.)
Figure 1. The Effect Theory
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Flow Chart showing how HCV can be used in an Effect Theory using a linear chart.
Adapted from “Health Program: Planning and Evaluation: A Practical Systematic Approach for
Community Health,” by L. M. Issel, 2009, pg. 181.

DNP Model of Care for a Rural Clinic
Although traditional treatment for hepatitis C is carried out in tertiary/hospital settings, a
rural clinic managed by a Doctor of Nursing Practice nurse, working in collaboration with a
hepatologist, can successfully evaluate and manage the multiple complications and side effects
commonly seen with hepatitis C treatment. Patient-centered availability, access to treatment
with cost savings benefits seen by nurse-managed clinics,23 allows a rural clinic for hepatitis C
an acceptable option for viral treatment. Below (Figure 2.) is the DNP Model of Care developed
by the author for those with chronic illness in a rural setting and used for the patient being treated
with hepatitis C. The patient is the focus of care with the DNP surrounding the outer circle of
the model as the manager of the care. Surrounding the patient are factors that influence
treatment outcomes, such as quality of life or completion of treatment, and failure to eradicate
the virus. In a rural setting the complicating factors for the patient will be different than care
within an urban setting, thus it is necessary to incorporate these into the surrounding boxes the
individual factors that may complicate treatment. (Figure 2.)

Figure 2. Krebbeks Doctor of Nursing Practice Model of Care
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A mission statement needs to be made for any clinic development. This should state the
purpose of the clinic, how I will be developed and how it will be evaluated.21 Clinical Objectives
also need to be established for a DNP managed HCV clinic. These include:
•

To increase awareness for the prevention of HCV to prevent new infections

•

To target lifestyle changes needed with HCV treatment

•

To improve access to HCV treatment

•

To provide services to those uninsured and underinsured

•

To provide a shorter time from diagnosis to treatment

•

To reduce the impact on health costs for treatment

•

To prevent the complications for cirrhosis associated with HCV

•

To obtain a sustained virological response early in treatment and 6 months
following completion of treatment

Once the mission statement and objectives for the clinic have been established,
implementing the plan of care for the patient with HCV will be followed using the guidelines of
the model of care and the theoretical framework which is consistent with the program purpose
and objectives. The patient is referred to the clinic from their primary care provider, OB/GYN or
from recent incarceration. On the first visit, the patient enters the clinic with a definite diagnosis
for HCV or may be referred to the clinic with abnormal liver function tests. The DNP will either
establish the diagnosis of HCV or confirm the presence of chronic active HCV through the
identification of active virus with a RNA quantitative viral load and genotyping of the virus.
Supplemental baseline laboratory testing is done at this first visit. These tests include a CBC,
chemistries, autoimmune and viral indices (HAV and HBV), ferritin level, TSH, HIV and HCG
for female patients and for partners of male patients if they are of child-bearing age. An
abdominal ultrasound is obtained on all patients to observe the contour of the liver. This may
give the DNP an indication if cirrhosis is already present. If any question exists, then an
ultrasound guided liver biopsy may be obtained, but mandatory liver biopsy is no longer
necessary prior to treatment.7 An informational packet is given to the patient at this first visit.
These packets contain information on the treatment drugs including how they are used with side
effects and cautions regarding their use. These drugs have a “black box warning”, meaning they
may have dangerous side effects under certain circumstances. It is important not to overwhelm
the patient at this point as they have received an extreme amount of information on this first visit.
Allowing an hour of time for this visit is not unusual.

The second visit is about 2-3 weeks later, allowing the results of all testing done to this
point to return. The DNP will review all the previous testing including the result of the viral
quantitative count. If confirmation of HCV is determined with a positive number, then a more
detailed discussion regarding the treatment is made. The patient is given a journal for recording
laboratory results, documenting exercise/physical activity done,24 and any questions or concerns
they may have. A patient/provider contract for treatment is reviewed and signed by both parties.
This contract contains patient responsibilities, including appointment visits, laboratory times, and
the importance of alcohol abstinence and the use of non-prescribed drugs. Of significance
importance is the understanding of not becoming pregnant or impregnating anyone else, as
treatment drugs for HCV are teratogenic. A dilated fundoscopic eye exam is important at the
beginning of treatment to determine any baseline abnormalities, as some abnormalities rarely
occur as a result of the treatment drugs bur usually subside after treatment completion. An
influenza immunization is recommended during the season and vaccination for HAV and HBV
are important if the patient has not had established immunity. Avoiding exposure to and
combating these other hepatitis viruses during treatment may be difficult.
Regular office visits occur at 1,2,4,6,8,12 and every 4 weeks thereafter until treatment is
completed. Laboratory testing is obtained at these times to assure no serious consequences are
occurring. Calculating and documenting serial absolute neutrophil counts (ANC) is important
when monitoring for serious side effects. Following medical protocol regarding these values is
essential. It is important to obtain a quantitative viral load at weeks 4,12,24,36, and 48, then 1, 3,
and 6 months post-treatment. Testing yearly thereafter has not been established. The patient is
weighed at each visit to monitor any loss. Some weight loss is expected but should not be
excessive. 25

Treatment and Screening for Hepatitis C
The standard treatment of care for HCV is well-documented by the American
Gastroenterological Association (AGA), American Association for the Study of Liver Diseases
(AASLD) and the New York State Department of Health (NYSDOH),11,12,26 which needs to be
followed by the DNP. Any deviation from those protocols needs to be discussed with the
collaborating physician first.
It is important for the patient to know how to administer these medications. The start of
treatment begins in the clinic office. The DNP or clinic nurse shows the patient how to
administer the medications with an emphasis on technique and hygiene. Safe disposal of the
used needles and syringes is essential for safety of the patient and any household members.
The baseline eye exam and subsequent exams during treatment are at the discretion of the
ophthalmologist performing the initial exam, and are important to follow any cotton-wool
exudates. Retinopathy is common with pegylated interferon, one of the treatment medications,
but most events clear after treatment is completed.27 The cost of treatment with pegylated
interferon and ribavirin is very high, about $30,000 per patient for the medication alone.2 The
National Surveillance Program calculated the cost of screening for HCV to be $1,246 per case
detected, though other studies have shown the cost between $374 and $1.047 per case detected.8
HCV screening and early treatment has the potential to improve average life-expectancy but
should focus only on those at high risk for the virus,28 as screening those without risk factors has
not been proven to be cost-effective. Approximately 30% of patients identified with chronic
HCV have normal liver tests but upon liver biopsy, have some degree of liver damage, thus it
remains very important to screen for those with current or past risk behavior for the virus.14

The future treatment for HCV will soon change. The addition of protease inhibitors are
currently being evaluated by the Federal Drug Administration (FDA) and will be added to
standard treatment, but their exact role is yet to be determined.29 The identification of genetic
variations with response to treatment may also influence viral eradication.30 These changes are
expected to occur mid to late 2011. The large tertiary clinics should be able to incorporate these
changes with little difficulty, but the rural areas may find resources and funding difficult to
manage. Despite this, the management of HCV treatment in a rural setting should be reasonable
with a workable model of care and a collaborating health team.
Evaluation Plan
Evaluating this model of nursing care needs to include both quantitative and qualitative
outcomes. Mentioned previously are quality of life concerns regarding HCV. Observation by
the DNP during office visits, conversation with patients and families with review of journal
entries are all forms of qualitative measurements. Quantitative measurements may include
compliance with office appointments, medication adherence and successful eradication of the
virus at completion of the treatment contract. Some of these measurements can be seen through
the monitoring of laboratory values, the expected depletion of medication, acceptable with
changes and lack of legal involvement.
Clinical conferences with collaborators involved in those patients undergoing HCV
treatment will be essential for the success of the clinic. Effective leadership by the DNP
manager will require a strong support staff with those wanting to make a difference, the creation
of ideas and actions, creativity with energetic and committed followers.31 This author advocates
a “circle network” that allows and encourages information to move from one member to another
equally. Communication is simplified and members have easy access to other member’s

thoughts32 and team members share responsibility for achieving the common goals of the
clinic.33 Familiarity among staff members of the clinic is also important for the patients. With a
small group in a rural setting, this management structure should be very effective.
An evaluation plan of the program must include operating costs of the clinic. One
method to do this uses the break-even analysis tool. This mathematical calculation divides the
fixed cost of operation of the clinic into the cost per patient equaling the number of patients
needed to be seen.21 This analysis should be done before the operational of the clinic begins,
early in its operation and throughout its management. Unfortunately, lack of health insurance
can be a critical factor in treating this potentially vulnerable population. Medicare and Medicaid
can underestimate actual costs for providing services which can greatly affect operational costs.
If patients have no health insurance, it is essential for them to apply for financial assistance for
both their advantage and for the security of the clinic. At one point a potential solution for those
looking to start an independent, rural clinic was H.R. 2754, to amend the Public Health Service
Act to establish the Nurse-Managed Health Clinic Investment Program, and other purposes, may
have be an option,34 but unfortunately the bill did not become a law, but may be presented again
with the next session of Congress. Another solution is to incorporate the nurse-managed clinic
into an existing gastroenterology or primary care practice to help defray the costs. Sharing of
office equipment and staff with the DNP providing care to those with HCV along with patients
with other health problems may need to be done until the clinic is financially secure. A third
method to provide cost-effective care is the use of telemedicine. Its use in rural and prison
settings allows providers to effectively manage patients with chronic illness.35 The Process
Theory showing the components of the organizational and service plans may be used for a nursemanaged clinic as shown below. (Figure 3.)

Figure 3. The Process Theory, Evaluation Flow Chart
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Work Flow
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Flow chart showing how a logic model as a tool for program evaluation may be used for
HCV. Adapted from “Health Program” Planning and Evaluation: A Practical Systematic
Approach for Comminity Health”, by Issel, LM. 2009, pg. 276.

Conclusion
As health care becomes more complex, evidence-based practice with collaboration
among multiple health disciplines needs to be implemented. Cost effective care with positive
outcomes and individualized care with innovation will be necessary. The IOM suggests
knowledge about this disease is poor1 and significant stigma surrounds the diagnosis.36 With an
accepted and useful model of care, theoretical framework with an ongoing evaluation tool, a
hepatitis C clinic within a rural setting can be successfully managed by a DNP prepared nurse.
Using the Effect and Process Theory, with the DNP Model of Care, patients with HCV can be
provided quality, culturally sensitive and cost-effective care. With the IOM’s concern regarding
the spread of HCV and Healthy People 2020 including communicable disease a national concern,
a DNP nurse-managed clinic can fill the gap and meet the need for addressing this “global
epidemic”.
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Figure 3. The Process Theory, Evaluation Flow Chart
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break-even analysis

Time line
Anticipated start date 7/1/11

Organizational chart
Circle Network
DNP/MD
MT/Receptionist
(Bolman & Deal, pg 106)

Operational Manual
Office Protocol
visit times/freq/vital signs, flow
chart, patient log

Social marketing
Product-treatment
Price-ins coverage
Place-exist office
Promotion-posters/speaking

Outputs
Coverage
Ins
Private pay, sliding fees
Indigent Coverage from
drug manufacturer

Units of Service
Frequency of Lab testing,
Number of Visits
Length of Treatment
(Patient flow sheet)

Materials produced
Number of pts in tx
Continued and completed tx
Number of pts with SVR

Work Flow
# of pts seen
Need for regular staff meetings
Staff education

